ITM Isotope Technologies to acquire Telix Pharmaceuticals for $1.65 billion

ITM Isotope Technologies announced it will acquire Telix Pharmaceuticals in a deal valued at a minimum of $1.65 billion. This merger follows a surprise FDA rejection faced by one of the companies, prompting consolidation in the radiopharmaceutical sector.

Originally published by gnews